Page ARTICLE I Purchase and Sale of Common Stock and Warrants 1 Section 1.1 Purchase and Sale of Common Stock and Warrants 1 Section 1.2 Purchase Price and Closing 1 Section 1.3 Warrants 2 Section 1.4 Warrant Shares 2 Section 1.5 Subsequent Third...Securities Purchase Agreement • May 18th, 2010 • ImmunoCellular Therapeutics, Ltd. • Pharmaceutical preparations • Delaware
This SECURITIES PURCHASE AGREEMENT this (“Agreement”), dated as of May 12, 2010, by and among ImmunoCellular Therapeutics, Ltd., a Delaware corporation (the “Company”), and the entities listed on Exhibit A hereto (each, a “Purchaser” and collectively, the “Purchasers”), for the purchase and sale by the Purchasers of shares of the Company’s Common Stock, par value $0.0001 per share (the “Common Stock”), and warrants to purchase shares of Common Stock.
FORM OF REGISTRATION RIGHTS AGREEMENTForm of Registration Rights Agreement • May 18th, 2010 • ImmunoCellular Therapeutics, Ltd. • Pharmaceutical preparations • California
This Registration Rights Agreement (this “Agreement”) is made and entered into as of May , 2010, by and among ImmunoCellular Therapeutics, Ltd., a Delaware corporation (the “Company”), and those securityholders of the Company appearing as signatories hereto (the “Investors”).
AMENDMENT TO LICENSE AGREEMENTLicense Agreement • May 18th, 2010 • ImmunoCellular Therapeutics, Ltd. • Pharmaceutical preparations
Re: License Agreement, dated as of 03/01/2008, by and between ImmunoCellular and Regent Business Centers Woodland Hills, LLC as Licensor.
